Group items tagged

"This report provides detailed historical analysis of global market for Container Glass from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Container Glass market. Leading players of Container Glass including: * Vetropack Hol * Owens Illinois Inc.ding Ltd * S.A.B de CV * Hindustan National Glass & Industries Ltd * Saint Gobain S.A "

"The global pharmacovigilance market size is expected to reach USD 11.64 billion by 2026. It is projected to expand at a CAGR of 13.3% during the forecast period. Increasing incidence of Adverse Drug Reactions (ADR) is the key growth driver. The U.S. Food and Drug Administration (FDA) received approximately 253,017 serious adverse events and 44,693 deaths associated with ADRs in 2015. This shows the potential demand for implementing safety and Pharmacovigilance (PV) services."

"The global biodefense market size is expected to reach USD 6.50 billion by 2025, growing at a CAGR of 4.5% over the forecast period. The market is majorly driven by rising focus of the public agencies on mitigating the risk of Chemical, Biological, Radiological and Nuclear (CBRN) threats and increased funding for biodefense. Biomedical Advanced Research and Development Authority (BARDA), National Interagency Confederation for Biological Research (NICBR), and National Institute of Allergy and Infectious Diseases (NIAID) are major organizations that provide financial support for biodefense research and stockpiling in U.S."

"The 'Global Fructooligosaccharide (FOS) Market Outlook 2018-2023' offers detailed coverage of fructooligosaccharide industry and presents main market trends. The market research gives historical and forecast market size, demand, end-use details, price trends, and company shares of the leading fructooligosaccharide producers to provide exhaustive coverage of the market for fructooligosaccharide. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography. The report has been prepared based on an in-depth market analysis with inputs from key industry participants. The global fructooligosaccharide market has been segmented into five major regions, namely, North America (U.S., Canada, and others), Europe (U.K., France, Germany, Russia, and others), Asia-Pacific (China, Japan, India, Australia, and others), South America (Brazil, Argentina, and others), and Middle East & Africa (South Africa, Saudi Arabia, and others). Furthermore, the report also includes an in-depth competitive analysis of the key vendors operating in this market."

"The global hand care market size is anticipated to reach USD 16.9 billion by 2025, expanding at a CAGR of 4.5%. The market is driven by increasing health, hygiene, and wellness concerns, risks of communicable diseases, rise in health expenditure, and change in lifestyle. The market finds vast applications, majorly focusing on hand hygiene. According to WHO, the primary measure to reduce infections is hand hygiene. Moreover, challenges like "Clean Care is Safer Care" by WHO to improve and promote hygiene practices and standards are contributing to the growth of the hand care market. In 2018, the hand wash segment held the largest share of over 40.0% owing to its benefits of providing basic hygiene. Based on the U.S. Census data and Simmons National Consumer Survey (NHCS), 298.63 million Americans used liquid hand wash. The sanitizer segment is expected to expand at a CAGR of 4.8% over the forecast period due to its hassle free use. The beauty products market is also expected to witness significant growth over the next few years due to availability of a large variety of care solutions catering to specific problems. These products include moisturizers and sunscreens. For instance, a new e-commerce startup named Public Goods, which deals in hand care products with natural and organic products, have moisturizers and sunscreens to protect the skin."

The global breast cancer drug market size is expected to reach USD 38.4 billion by 2025. It is projected to expand at a CAGR of 10.7% during the forecast period. Early detection, increase in awareness, and incidence of breast cancer are some of the key trends stoking market growth. Global breast cancer drugs market is expected to grow lucratively as many players focus majorly on R&D of innovative treatments. They engage in extensive research to develop novel drugs for the treatment of the disease to gain a higher market share. There exists a growing pressure and need for novel therapies and treatment due to rapidly accelerating prevalence of diseases. The strong pipeline is expected to provide new and effective treatment options and improved outcomes than existing therapies. With advancements in drug delivery systems, various target specific therapies have been customized and designed as a carrier to infuse the therapeutic agent to the target site. Carriers for inducing target therapy include modified anticancer agent's specific to molecular-recognition-element, anticancer peptides, and nanoparticle-based anticancer drugs. For instance, HER2/neu protein is usually given in combination with other anti-cancer drugs in targeted therapy. Get Free Sample Copy of this Report at at: https://www.radiantinsights.com/research/breast-cancer-drugs-market/request-sample F. Hoffman-La Roche Ltd leads the breast cancer drugs market with Herceptin, Perjeta, and Kadcyla. However, rapid advancements in biosimilars with a goal to offer cost effective alternatives to patients is anticipated to put pressure on this space. For instance, in December 2017, the Food and Drug Administration (FDA) approved the first biosimilar of trastuzumab for HER2+ breast cancer. Further key findings from the report suggest: * HER2 inhibitors is expected to be the most preferred drug class segment over the forecast period, owing to their high specificity as they are subclass of target therapy *